Maxcyte Income Statement (2020-2025) | MXCT

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 5.15M6.76M8.51M6.49M7.11M10.14M10.15M11.59M9.61M10.64M12.42M8.58M9.04M8.00M15.66M11.34M10.43M8.16M8.69M10.39M8.51M6.83M
Gross Profit 4.68M6.03M7.61M5.80M6.32M9.20M8.93M10.52M8.49M9.27M10.88M7.58M7.67M7.21M14.09M9.94M8.94M6.24M6.41M8.89M6.99M5.23M
Operating items
Depreciation & Amortization - Total 1.08M1.07M1.09M1.06M
Research & Development 4.09M4.52M4.88M6.08M3.20M2.75M3.38M3.77M4.70M5.33M5.73M6.05M5.66M6.26M5.84M6.68M5.62M5.32M4.61M5.90M6.27M5.32M
Wages, Salaries and Other 3.06M
Selling, General & Administrative 1.59M2.31M1.69M3.00M4.30M5.35M6.03M6.63M7.10M6.44M5.65M7.50M7.66M6.82M8.09M7.10M7.64M7.75M7.21M8.53M8.08M6.03M
Other Operating Expenses 1.84M2.04M3.42M3.10M3.24M3.54M4.47M4.29M5.43M5.22M6.25M7.21M7.41M8.08M8.26M-11.37M-11.07M-13.22M7.49M-10.92M-12.36M-12.42M
Operating Expenses 7.53M8.87M9.99M12.17M10.74M11.64M13.88M14.68M17.23M16.99M17.63M20.75M20.74M21.16M22.19M22.21M20.91M20.29M19.31M21.19M21.21M19.38M
Operating Income -2.84M-2.84M-2.38M-6.37M-4.42M-2.44M-4.96M-4.16M-8.74M-7.71M-6.75M-13.18M-13.07M-13.95M-8.10M-12.28M-11.97M-14.05M-12.90M-12.29M-14.23M-14.15M
EBIT -2.84M-2.84M-2.38M-6.37M-4.42M-2.44M-4.96M-4.16M-8.74M-7.71M-6.75M-13.18M-13.07M-13.95M-8.10M-12.28M-11.97M-14.05M-12.90M-12.29M-14.23M-14.15M
Non-operating items
Interest & Investment Income 0.01M0.01M0.01M0.01M0.01M0.05M0.08M0.09M0.48M1.39M1.95M2.30M2.56M2.70M2.82M2.75M2.59M2.50M2.30M2.03M1.87M1.73M
Other Non Operating Income -0.16M-0.26M-0.27M-0.73M-0.00M-0.24M0.08M0.09M0.48M1.28M1.94M2.30M2.56M2.70M2.82M2.75M2.59M2.50M2.30M2.03M1.87M1.73M
Non Operating Income -0.16M-0.26M-0.27M-0.73M-0.00M-0.24M0.08M0.09M0.48M1.28M1.94M2.30M2.56M2.70M2.82M2.75M2.59M2.50M2.30M2.03M1.87M1.73M
Net income details
EBT -3.00M-3.10M-2.65M-7.11M-4.42M-2.68M-4.87M-4.07M-8.26M-6.43M-4.81M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M
Profit After Tax -3.00M-3.10M-2.65M-7.11M-4.42M-2.68M-4.87M-4.07M-8.26M-6.43M-4.81M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M
Income from Continuing Operations -3.00M-3.10M-2.65M-7.11M-4.42M-2.68M-4.87M-4.07M-8.26M-6.43M-4.81M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M
Consolidated Net Income -3.00M-3.10M-2.65M-7.11M-4.42M-2.68M-4.87M-4.07M-8.26M-6.43M-4.81M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M
Income towards Parent Company -3.00M-3.10M-2.65M-7.11M-4.42M-2.68M-4.87M-4.07M-8.26M-6.43M-4.81M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M
Net Income towards Common Stockholders -3.00M-3.10M-2.65M-7.11M-4.42M-2.68M-4.87M-4.07M-8.26M-6.43M-4.81M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M
Additional items
EPS (Basic) -0.05-0.04-0.03-0.09-0.05-0.03-0.05-0.04-0.08-0.06-0.05-0.11-0.10-0.11-0.05-0.09-0.09-0.11-0.10-0.10-0.12-0.12
EPS (Weighted Average and Diluted) -0.05-0.04-0.03-0.09-0.05-0.03-0.05-0.04-0.08-0.06-0.05-0.11-0.10-0.11-0.05-0.09-0.09-0.11-0.10-0.10-0.12-0.12
Shares Outstanding (Weighted Average) 65.83M77.09M69.46M84.71M95.66M90.62M101.31M101.55M101.81M101.70M102.85M103.06M103.45M103.27M104.09M104.64M105.11M104.85M105.95M106.40M106.61M
Shares Outstanding (Diluted Average) 65.83M77.09M69.46M84.71M87.18M90.62M101.31M101.55M101.81M101.70M102.85M103.06M103.45M103.27M104.09M104.64M105.11M104.85M105.95M106.40M106.61M
EBITDA -2.84M-2.84M-2.38M-6.37M-4.42M-2.44M-4.96M-4.16M-8.74M-7.71M-6.75M-13.18M-13.07M-13.95M-8.10M-12.28M-10.89M-12.99M-12.90M-12.29M-13.14M-13.09M
Interest Expenses 0.16M0.26M0.28M0.74M0.01M0.29M0.12M0.01M
Shares Outstanding 76.59M77.29M77.38M84.72M100.43M101.20M101.51M101.66M101.90M102.40M102.90M103.13M103.55M103.96M104.41M104.82M105.30M105.71M106.31M106.59M106.64M